Arkolith/Insider Trading/BNGO/Form 4

Linney Yvonne

DirectorBionano Genomics, Inc. (BNGO) · full profile →Form 4 · filed Aug 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$72K
Net Open-Market Flow
-$72K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2022Option exercise(M)20K$0.38$8K20K
Aug 15, 2022Sell(S)20K$3.62$72K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 15, 2022Option exercise(M)20K—$061K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001411690-22-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Bionano Genomics, Inc.

Build

Ask your agent about BNGO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001411690-22-000023"
Ask your agent
Use Arkolith to summarize insider buying and selling at Bionano Genomics, Inc.
over the last 90 days and cite the filings.